165 related articles for article (PubMed ID: 16998465)
21. An unusual case of CD4+ CD7+ CD56+ acute leukemia with overlapping features of type 2 dendritic cell (DC2) and myeloid/NK cell precursor acute leukemia.
Anargyrou K; Paterakis G; Boutsis D; Politou M; Papadhimitriou SI; Siakandaris M; Vassiliadis J; Androulakis A; Meletis J; Rombos J; Tassiopoulou A; Vaiopoulos G
Eur J Haematol; 2003 Oct; 71(4):294-8. PubMed ID: 12950240
[TBL] [Abstract][Full Text] [Related]
22. Isolation of myeloid and plasmacytoid dendritic cells from human bronchoalveolar lavage fluid.
Tsoumakidou M; Tzanakis N; Papadaki HA; Koutala H; Siafakas NM
Immunol Cell Biol; 2006 Jun; 84(3):267-73. PubMed ID: 16509829
[TBL] [Abstract][Full Text] [Related]
23. Plasmacytoid dendritic cell leukemia in children.
Hama A; Kudo K; Itzel BV; Muramatsu H; Nishio N; Yoshida N; Takahashi Y; Yagasaki H; Ito M; Kojima S
J Pediatr Hematol Oncol; 2009 May; 31(5):339-43. PubMed ID: 19415013
[TBL] [Abstract][Full Text] [Related]
24. CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate.
Leitenberger JJ; Berthelot CN; Polder KD; Pro B; McLaughlin P; Jones D; Duvic M
J Am Acad Dermatol; 2008 Mar; 58(3):480-4. PubMed ID: 18280345
[TBL] [Abstract][Full Text] [Related]
25. Immunophenotypic CD56 Variation Within a Single Patient With Blastic Plasmacytoid Dendritic Cell Neoplasm.
Lopez AT; Shaw KS; Yamany T; Husain S; Geskin L
JAMA Dermatol; 2018 Apr; 154(4):492-494. PubMed ID: 29490374
[No Abstract] [Full Text] [Related]
26. Cutaneous CD4+ CD56+ hematologic malignancies.
Magro CM; Porcu P; Schaefer J; Erter JW; Furman RR; Shitabata PK; Crowson AN
J Am Acad Dermatol; 2010 Aug; 63(2):292-308. PubMed ID: 20541283
[TBL] [Abstract][Full Text] [Related]
27. Infantile CD4+/CD56+ hematodermic neoplasm.
Hu SC; Tsai KB; Chen GS; Chen PH
Haematologica; 2007 Sep; 92(9):e91-3. PubMed ID: 17768139
[No Abstract] [Full Text] [Related]
28. Blastic plasmacytoid dendritic cell neoplasm presenting as leukemia without cutaneous lesion.
Awasthi NP; Qayoom S; Dabadghao S
J Cancer Res Ther; 2017; 13(6):1056-1058. PubMed ID: 29237977
[TBL] [Abstract][Full Text] [Related]
29. Chronic myelomonocytic leukemia and blastic plasmacytoid dendritic cell neoplasm. A case report and systematic review.
Espasa A; Sorigue M; Tapia G; Cabezon M; Vergara S; Raya M; Navarro JT; Junca J; Zamora L; Xicoy B
Cytometry B Clin Cytom; 2021 May; 100(3):292-295. PubMed ID: 32830878
[No Abstract] [Full Text] [Related]
30. Non-B, non-T neoplasms with lymphoblast morphology: further clarification and classification.
Karube K; Ohshima K; Tsuchiya T; Yamaguchi T; Suefuji H; Suzumiya J; Harada M; Kikuchi M
Am J Surg Pathol; 2003 Oct; 27(10):1366-74. PubMed ID: 14508398
[TBL] [Abstract][Full Text] [Related]
31. CD4+/CD56+ hematodermic neoplasm: presentation of 2 cases and review of the concept of an uncommon tumor originated in plasmacytoid dendritic cells expressing CD123 (IL-3 receptor alpha).
Piña-Oviedo S; Herrera-Medina H; Coronado H; Del Valle L; Ortiz-Hidalgo C
Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):481-6. PubMed ID: 18091395
[TBL] [Abstract][Full Text] [Related]
32. CD4+ CD56+ hematodermic neoplasm and plasmacytoid dendritic cell tumor: case report and review of the literature.
Campbell SM; Moad JC; Sammons DL; Zirwas M
Cutis; 2012 Jun; 89(6):278-83. PubMed ID: 22838092
[TBL] [Abstract][Full Text] [Related]
33. A novel plasmacytoid dendritic cell line, CAL-1, established from a patient with blastic natural killer cell lymphoma.
Maeda T; Murata K; Fukushima T; Sugahara K; Tsuruda K; Anami M; Onimaru Y; Tsukasaki K; Tomonaga M; Moriuchi R; Hasegawa H; Yamada Y; Kamihira S
Int J Hematol; 2005 Feb; 81(2):148-54. PubMed ID: 15765784
[TBL] [Abstract][Full Text] [Related]
34. Detection of Minimal Bone Marrow involvement of Blastic Plasmacytoid Dendritic Cell Neoplastic Cells - CD303 immunostaining as a diagnostic tool.
Ohe R; Aung NY; Shiono Y; Utsunomiya A; Kabasawa T; Tamazawa N; Tamura Y; Kato T; Yamada A; Hasegawa S; Aizawa K; Inokura K; Ito S; Toubai T; Kato Y; Tsunoda T; Onami K; Suzuki T; Ishizawa K; Yamakawa M
J Clin Exp Hematop; 2018 Mar; 58(1):1-9. PubMed ID: 29415975
[TBL] [Abstract][Full Text] [Related]
35. Plasmacytoid dendritic cells: from the plasmacytoid T-cell to type 2 dendritic cells CD4+CD56+ malignancies.
Béné MC; Feuillard J; Jacob MC;
Semin Hematol; 2003 Jul; 40(3):257-66. PubMed ID: 12876674
[TBL] [Abstract][Full Text] [Related]
36. TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin.
Herling M; Teitell MA; Shen RR; Medeiros LJ; Jones D
Blood; 2003 Jun; 101(12):5007-9. PubMed ID: 12576313
[TBL] [Abstract][Full Text] [Related]
37. Cutaneous accumulation of plasmacytoid dendritic cells associated with acute myeloid leukemia: a rare condition distinct from blastic plasmacytoid dendritic cell neoplasm.
Dargent JL; Delannoy A; Pieron P; Husson B; Debecker C; Petrella T
J Cutan Pathol; 2011 Nov; 38(11):893-8. PubMed ID: 21883371
[TBL] [Abstract][Full Text] [Related]
38. Human BDCA2+CD123+CD56+ dendritic cells (DCs) related to blastic plasmacytoid dendritic cell neoplasm represent a unique myeloid DC subset.
Yu H; Zhang P; Yin X; Yin Z; Shi Q; Cui Y; Liu G; Wang S; Piccaluga PP; Jiang T; Zhang L
Protein Cell; 2015 Apr; 6(4):297-306. PubMed ID: 25779340
[TBL] [Abstract][Full Text] [Related]
39. [Blastic plasmacytoid dendritic cell neoplasm revealed by ecchymotic lesions on the face].
Ahogo KC; Wantz M; Cliquennois M; Gosset P; Lebas D; Modiano P
Ann Dermatol Venereol; 2014 Jan; 141(1):43-7. PubMed ID: 24461094
[TBL] [Abstract][Full Text] [Related]
40. Novel markers of normal and neoplastic human plasmacytoid dendritic cells.
Marafioti T; Paterson JC; Ballabio E; Reichard KK; Tedoldi S; Hollowood K; Dictor M; Hansmann ML; Pileri SA; Dyer MJ; Sozzani S; Dikic I; Shaw AS; Petrella T; Stein H; Isaacson PG; Facchetti F; Mason DY
Blood; 2008 Apr; 111(7):3778-92. PubMed ID: 18218851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]